Genetic epidemiology of coronary artery disease: an Asian Indian perspective

Shanker Jayashree1, Maitra Arindam, Kakkar V Vijay

  • 1Functional Genomics Thrombosis Research Institute, Bengaluru 560 099, India.jayashreeshanker@triindia.org.in.

Journal of Genetics
|October 7, 2015
PubMed

Insights

Genetic factors significantly influence coronary artery disease (CAD) risk, especially in Asian Indians. Further research is needed to clarify gene impacts on CAD susceptibility and incident risk.

Area of Science:

  • Cardiovascular Genetics
  • Population Health

Background:

  • Coronary artery disease (CAD) is a leading global cause of death.
  • Genetic factors play a role in CAD development, beyond lipid metabolism.
  • Understanding genetic predispositions in high-risk populations like South Asians is crucial.

Purpose of the Study:

  • To review and consolidate existing literature on the genetics of CAD in Asian Indians.
  • To identify knowledge gaps regarding specific genes and their impact on CAD susceptibility.
  • To guide future research for clinically relevant insights.

Main Methods:

  • Literature review of genetic studies on CAD in Asian Indians.
  • Analysis of identified gene polymorphisms and their association with CAD.
  • Assessment of data limitations and need for validation in large cohorts.

Main Results:

  • Novel genes and variants are implicated in CAD aetiopathology.
  • Current knowledge on specific gene identities and their impact on disease risk is limited.
  • Existing studies in Asian Indians are often isolated and lack validation.

Conclusions:

  • Consolidating current literature is essential for understanding CAD genetics in Asian Indians.
  • Further large-scale prospective studies are required to validate findings.
  • Generating clinically valuable information necessitates addressing current research limitations.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
983
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
857
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
84
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
569
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
98